Free Anti-Adalimumab

Free Anti-Adalimumab
Detecting the development of Anti-drug antibodies (ADAs) against Adalimumab in patients being treated with Adalimumab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Adalimumab can detect the presence of anti-drug antibodies against Adalimumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 12 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum
• Reaction Time 12 mins
  
• Detection Range 3-200 AU/mL
  
• Indication Semi-quantitative determination of antibodies against adalimumab in human whole blood/serum
  

Click